Obsessive-compulsive disorder affects an estimated 2 to 3 percent of the global population, yet it is one of the most misunderstood conditions in mental health — frequently dismissed as a personality quirk rather than recognized as the neurologically complex disorder it is (National Institute of Mental Health). Many people cycle through years of therapy and medication without finding adequate relief. At Awakenings by Northwest Ohio Ketamine in Toledo, we work with patients who have reached exactly that point and are looking for a different path forward.
What OCD Actually Is
Obsessive-compulsive disorder, commonly abbreviated as OCD, is a chronic mental health condition characterized by two core features: obsessions and compulsions. Obsessions are recurrent, unwanted thoughts, images, or urges that cause significant distress. Compulsions are repetitive behaviors or mental acts that a person feels driven to perform in response to an obsession — typically in an attempt to reduce anxiety or prevent a feared outcome (Mayo Clinic).
It is worth separating clinical OCD from the casual use of the term in everyday conversation. Saying you are “so OCD” about keeping your desk tidy is not the same as living with a disorder in which intrusive thoughts consume hours of your day and compulsive rituals interfere with work, relationships, and basic functioning. For people with true OCD, the cycle of obsession and compulsion is not a preference — it is a relentless mental loop that feels impossible to break. Our New OCD Treatment in Toledo is designed specifically for patients who have struggled to break that cycle through conventional means.
The Neurological Roots of OCD
Research into what causes OCD has shifted significantly toward the brain’s structure and chemistry. According to the National Institute of Mental Health, OCD is associated with differences in brain circuits that connect regions involved in judgment, planning, and the processing of strong emotions. The orbitofrontal cortex, the thalamus, and the caudate nucleus — components of a circuit sometimes called the cortico-striato-thalamo-cortical loop — appear to function differently in people with OCD than in those without it. When this circuit misfires, the brain essentially gets stuck, generating a persistent signal that something is wrong even when nothing is.
Serotonin, a neurotransmitter involved in mood regulation, has long been central to OCD research, which is why selective serotonin reuptake inhibitors (SSRIs — a class of antidepressant that increases serotonin availability in the brain) are typically the first medication tried. Glutamate, the brain’s primary excitatory neurotransmitter, has also emerged as a significant factor, particularly in cases where serotonin-targeted treatments fall short. This glutamate connection is one reason researchers have explored treatments that work through different pathways for patients who have not responded to conventional options.
Genetic and Environmental Contributors
OCD does not have a single cause. Instead, current evidence points to a combination of genetic vulnerability and environmental factors that together raise the likelihood of the disorder developing.
On the genetic side, OCD runs in families. People with a first-degree relative — a parent, sibling, or child — who has OCD are at meaningfully higher risk than the general population. This familial pattern is stronger when the relative developed OCD in childhood or adolescence, suggesting that early-onset OCD may have a particularly strong genetic component (Mayo Clinic). Researchers have identified variations in several genes involved in serotonin and glutamate transmission as potentially relevant, though no single “OCD gene” has been identified.
Environmental contributors include significant life stressors, trauma, and in some cases infections. A phenomenon called PANDAS — Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections — describes a subset of children who develop sudden, severe OCD symptoms following a strep infection, suggesting that immune system responses can, in some cases, trigger or worsen the disorder. Beyond infections, chronic stress, childhood adversity, and major life transitions have all been associated with OCD onset or worsening in people who are already neurologically predisposed. For a deeper look at how OCD symptoms can escalate over time, see our article on Can OCD Get Worse?
Why OCD Often Resists Standard Treatment
Standard first-line treatment for OCD typically combines cognitive-behavioral therapy (CBT), specifically a technique called exposure and response prevention (ERP), with SSRI medication. For many patients, this combination produces meaningful improvement. For a significant subset, however, it does not — and this is where treatment becomes more complex.
Treatment-resistant OCD refers to cases in which a patient has not responded adequately to multiple appropriate medication trials and structured therapy. The National Institute of Mental Health notes that research into new treatments for OCD is ongoing, with emerging evidence pointing to approaches that target the glutamate system rather than serotonin alone. This is directly relevant to what we offer at Awakenings. Therapeutic ketamine infusions work primarily through the glutamate system — specifically by blocking a receptor called the NMDA receptor (N-methyl-D-aspartate receptor) — which gives them a fundamentally different mechanism of action than the medications most OCD patients have already tried.
Addressing Common Barriers to Seeking Care
Two things frequently prevent people from pursuing evaluation or advanced treatment for OCD: stigma and uncertainty about cost.
The stigma surrounding OCD is real. Because the disorder is so often portrayed inaccurately — as a preference for cleanliness or symmetry rather than a serious neurological condition — people living with severe OCD sometimes feel their suffering is not taken seriously. At Awakenings, we take a different view. We treat OCD as the complex, often treatment-resistant condition it is, and every patient who comes to us has already demonstrated considerable resilience simply by continuing to seek care.
On the cost side, we do not accept insurance as a primary payer, but some insurance companies will cover all or a portion of treatment as an out-of-network service. If yours does, we will provide you with the documentation needed to submit a claim. We also offer financing through CareCredit, a medical funding company, for patients who need to spread the cost of treatment over time. Additionally, we extend a 25 percent discount to active and former military with valid ID or DD-214 and to first responders with a badge. Our team will walk through the financial picture with you before you make any commitment.
What Evaluation Looks Like at Awakenings
Before any treatment is recommended, we begin with a free initial consultation to review your history, prior diagnoses, and what you have already tried. Dr. William James, our founder and director, brings a background in anesthesiology and deep expertise in ketamine treatment in Toledo, Ohio. Ben Wagner, PMHNP-BC, our board-certified Psychiatric Mental Health Nurse Practitioner, has seven years of clinical experience across a range of settings including inpatient behavioral health and ketamine-assisted therapy — he brings the behavioral health depth that complex OCD cases require. Together, our team evaluates whether IV ketamine infusion therapy may be appropriate for your specific situation.
Results vary by individual, and IV ketamine is not suitable for every patient. Certain medical and psychiatric histories may affect candidacy, which is why a thorough evaluation comes before any treatment recommendation. We encourage you to discuss all your options with our providers and with any other clinicians currently involved in your care. You can also browse our Ketamine FAQs for answers to the most common questions patients bring to their first visit.
Frequently Asked Questions
Is OCD a serious mental health condition or just a personality type? OCD is a clinically recognized neurological disorder, not a personality trait or preference. It involves measurable differences in brain circuit function and causes significant distress and functional impairment for those who live with it. It is not the same as being particular or organized.
Why doesn’t OCD always respond to antidepressants? Standard antidepressants — primarily SSRIs — target the serotonin system. OCD also involves the glutamate system, which SSRIs do not directly address. For patients whose OCD is driven in part by glutamate dysregulation, serotonin-targeted medications may produce limited or no benefit, which is one reason alternative approaches are being studied.
Is IV ketamine FDA-approved for OCD? IV ketamine is not FDA-approved specifically for OCD. It is used off-label, meaning it is administered by qualified medical providers for conditions outside its FDA-approved indications based on clinical evidence and physician judgment. We discuss what this means for your specific situation during your consultation.
How do I know if I’m a candidate for ketamine therapy for OCD? Candidacy depends on your full medical and psychiatric history, prior treatment responses, and other individual factors. The best first step is scheduling a free consultation with our team at Awakenings, where we can review your history and give you an honest assessment.
What should I bring to my first appointment? It helps to bring documentation of prior diagnoses and any records of medications you have tried, including doses and how long you took them. If you have worked with a therapist or psychiatrist, a referral is welcome but not required.
Key Takeaways
- OCD is a neurological disorder involving differences in brain circuits that connect regions responsible for judgment, emotion, and repetitive behavior — it is not a personality trait.
- Both serotonin and glutamate systems are implicated in OCD, which is why serotonin-targeted medications alone do not work for every patient.
- Genetic vulnerability, family history, stress, and in some cases immune responses all contribute to OCD risk — it is not caused by any single factor.
- Treatment-resistant OCD — cases that have not responded adequately to standard therapy and medication — is a recognized clinical challenge with emerging treatment options.
- At Awakenings in Toledo, we offer free initial consultations to evaluate whether IV ketamine infusion therapy may be appropriate; results vary by individual and candidacy requires a thorough clinical review.
If standard OCD treatment has not given you the relief you were hoping for, that does not mean nothing will. At Awakenings by Northwest Ohio Ketamine in Toledo, we offer a free initial consultation to review your history and discuss whether IV ketamine infusion therapy may be a viable next step. Call us at 419-406-4263 or schedule a consultation to get started.
References
Mayo Clinic. Obsessive-compulsive disorder (OCD) — Symptoms and causes. https://www.mayoclinic.org/diseases-conditions/obsessive-compulsive-disorder/symptoms-causes/syc-20354432
National Institute of Mental Health. Obsessive-Compulsive Disorder (OCD). https://www.nimh.nih.gov/health/topics/obsessive-compulsive-disorder-ocd
Medical Disclaimer
The information in this blog is for educational purposes only and does not constitute medical advice. IV ketamine therapy for OCD should only be considered under the supervision of a qualified medical provider familiar with your full medical and psychiatric history. Individual results vary. If you are experiencing a mental health crisis or thoughts of self-harm, please call or text 988 to reach the Suicide and Crisis Lifeline or go to your nearest emergency room.